JPRN-UMIN000016807
Completed
N/A
Pathophysiology clarification of spasmodic dysphonia by functional MRI - Analysis of spasmodic dysphonia by fMRI
Graduate School of Medicine, Kyoto University0 sites22 target enrollmentJune 1, 2015
ConditionsSpasmodic dysphonia
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Spasmodic dysphonia
- Sponsor
- Graduate School of Medicine, Kyoto University
- Enrollment
- 22
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
We found overactivation in the left sensorimotor cortex and the left thalamus in SD patients, suggesting that voice perception activates different neural systems between SD patients and healthy participants. For SD patients, moreover, the magnitude of sensorimotor activation showed a significant positive correlation with symptom severity measured by voice handicap index-10, suggesting that signals from the sensorimotor cortex can be a new biomarker for assessing disease severity.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients of dysphasia, organic disease of vocal code History of botulinum toxin treatment less than 6 months before participation Patients of mental disease Patients of abuse of alchocol or medication
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
Phase 2
A Phase 2 Trial of Deep Brain Stimulation for Spasmodic DysphoniaSpasmodic DysphoniaNCT04938154University of British Columbia16
Completed
N/A
Neuropathology of Spasmodic DysphoniaVoice DisordersSpasmodic DysphoniaHealthyMovement DisorderFocal DystoniaNCT00118586National Institute of Neurological Disorders and Stroke (NINDS)97
Completed
N/A
Thalamic Deep Brain Stimulation for Spasmodic Dysphonia- DEBUSSY TrialSpasmodic DysphoniaLaryngeal DystoniaDeep Brain StimulationNCT02558634University of British Columbia6
Completed
Phase 2
Voice Tremor in Spasmodic Dysphonia: Central Mechanisms and Treatment ResponseSpasmodic DysphoniaVoice TremorNCT01961297Kristina Simonyan53
Completed
Phase 1
DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic DysphoniaAdductor Spasmodic DysphoniaVoice DisordersSpasmodic DysphoniaNCT05158166University of California, San Francisco22